Refine
Has Fulltext
- yes (13)
Is part of the Bibliography
- yes (13)
Document Type
- Journal article (12)
- Doctoral Thesis (1)
Keywords
- SARS-CoV-2 (3)
- ceramides (3)
- sphingolipids (3)
- super-resolution microscopy (2)
- Aspergillus fumigatus (1)
- CCL3 (1)
- CCL4 (1)
- CCL5 (1)
- CD28 (1)
- Click-Chemie (1)
- Einzelmolekülmikroskopie (1)
- HIV (1)
- Lipid Raft (1)
- Lipide (1)
- Moleküle (1)
- Neisseria (1)
- Neisseria meningitidis (1)
- Sphingolipide (1)
- Superagonistic antibody (1)
- Th1 cells (1)
- Visualisierung (1)
- Zellen (1)
- acid sphingomyelinase (1)
- antimicrobials (1)
- azido-ceramides (1)
- bacterial infection (1)
- biological techniques (1)
- capacitance (1)
- cell membranes (1)
- ceramidase (1)
- ceramide (1)
- ceramide analogs (1)
- confocal laser microscopy (1)
- corticosteroids (1)
- cytokine release (1)
- cytosol (1)
- dSTORM (1)
- endosomes (1)
- fluoxetine (1)
- fungal infection (1)
- gangliosides and lipid rafts (1)
- glycosphingolipids (1)
- imaging (1)
- interferon γ (1)
- intracellular membranes (1)
- labeling techniques (1)
- lipid rafts (1)
- measles (1)
- membrane proteins (1)
- microbiology (1)
- microbiology techniques (1)
- microscopy (1)
- nanoscale imaging (1)
- natural killer cell (1)
- natural killer cells (1)
- pattern recognition receptors (1)
- single-molecule tracking (1)
- sphingolipid expansion microscopy (1)
- sphingomyelinase (1)
- sphingosine 1-phosphate (1)
- stem cell transplantation (1)
- vesicles (1)
Recently, we have shown that C6-ceramides efficiently suppress viral replication by trapping the virus in lysosomes. Here, we use antiviral assays to evaluate a synthetic ceramide derivative α-NH2-ω-N3-C6-ceramide (AKS461) and to confirm the biological activity of C6-ceramides inhibiting SARS-CoV-2. Click-labeling with a fluorophore demonstrated that AKS461 accumulates in lysosomes. Previously, it has been shown that suppression of SARS-CoV-2 replication can be cell-type specific. Thus, AKS461 inhibited SARS-CoV-2 replication in Huh-7, Vero, and Calu-3 cells up to 2.5 orders of magnitude. The results were confirmed by CoronaFISH, indicating that AKS461 acts comparable to the unmodified C6-ceramide. Thus, AKS461 serves as a tool to study ceramide-associated cellular and viral pathways, such as SARS-CoV-2 infections, and it helped to identify lysosomes as the central organelle of C6-ceramides to inhibit viral replication.